Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/177255
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study |
Autor: | Gonzalo-Calvo, David de CSIC ORCID; Cediel, Germán; Bär, Christian; Núñez,Julio; Revuelta-López, Elena; Gavara, Josep; Ríos-Navarro, César; Llorente-Cortés, Vicenta CSIC ORCID; Bodí, Vicente; Thum, Thomas; Bayés Genís, Antoni | Fecha de publicación: | 11-oct-2018 | Editor: | Nature Publishing Group | Citación: | Scientific Reports 8: 15115 (2018) | Resumen: | Reliable noninvasive prognostic biomarkers for left ventricular (LV) remodeling in ST-segment elevation myocardial infarction (STEMI) are needed. This study aimed to evaluate a panel of circulating microRNAs (miRNAs) as biomarkers of LV remodeling using cardiovascular magnetic resonance (CMR). We prospectively evaluated patients with a first STEMI treated with primary percutaneous coronary intervention who underwent CMR imaging at 1 week and 6 months after STEMI (n = 70). miRNAs were measured using PCR-based technologies in plasma samples collected at admission. The associations between miRNAs and LV diastolic and systolic volumes, and ejection fraction at 6-months were estimated in adjusted models. Median age was 60 years, 71.4% were male. miR-1254 was significantly associated in univariate analyses. Patients in the highest tertile of miR-1254 exhibited lower values of LVEDVI and LVESVI and higher values of LVEF at 1 week. After comprehensive multivariate adjustment including clinical, CMR variables, hs-troponin-T and NT-proBNP, miRNA-1254 was associated with decreasing LVESVI (P = 0.006), and borderline negative associated with LVEDVI (P = 0.063) at 6-months. miR-1254 also exhibited a significant positive association with increasing LVEF during follow-up (P < 0.001). Plasma miRNA-1254 predicted changes in LV volumes and LVEF at 6 months after STEMI. The value of miR-1254 to inform tailored treatment selection and monitor ongoing efficacy deserves further investigation. | Versión del editor: | https://doi.org/10.1038/s41598-018-33491-y | URI: | http://hdl.handle.net/10261/177255 | DOI: | 10.1038/s41598-018-33491-y | E-ISSN: | 2045-2322 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Circulating miR-1254_GonzaloCalvo.pdf | 1,18 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
16
checked on 15-abr-2024
SCOPUSTM
Citations
22
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
21
checked on 28-feb-2024
Page view(s)
163
checked on 17-abr-2024
Download(s)
139
checked on 17-abr-2024